Mainz Biomed B.V. Shareholders' Equity for the year ending December 31, 2024: USD 6.05 M

Mainz Biomed B.V. Shareholders' Equity is USD 6.05 M for the year ending December 31, 2024, a 86.09% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Mainz Biomed B.V. Shareholders' Equity for the year ending December 31, 2023 was USD 3.25 M, a -76.95% change year over year.
  • Mainz Biomed B.V. Shareholders' Equity for the year ending December 31, 2022 was USD 14.10 M, a 121.60% change year over year.
  • Mainz Biomed B.V. Shareholders' Equity for the year ending December 31, 2021 was USD 6.36 M, a -332.03% change year over year.
  • Mainz Biomed B.V. Shareholders' Equity for the year ending December 31, 2020 was USD -2.74 M.
Key Data
Date Shareholders' Equity Cash and Short-Term Investments Receivables Inventory